位置:成果数据库 > 期刊 > 期刊详情页
Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells
  • ISSN号:1000-467X
  • 期刊名称:《癌症:英文版》
  • 分类:Q78[生物学—分子生物学] TQ463.5[化学工程—制药化工]
  • 作者机构:[1]State Key Laboratory of Oncology in SouthChina, Guangzhou, Guangdong 510060, P. R. China, [2]Departmentof Experimental Research, Sun Yat-sen University Cancer Center,Guangzhou, Guangdong 510060, P. R. China, [3]Department ofBiotherapy Center, Sun Yat-sen University Cancer Center, Guangzhou,Guangdong 510060, P. R. China, [4]Guangzhou ImVin PharmaceuticalsCo., Ltd, Guangzhou, Guangdong 510663, P. R. China.
  • 相关基金:Acknowledgments This work was supported by grants from the National Natural Science Foundation of China (No. u0772002, No. 30700985, No. 30973398) and the Guangdong Natural Science Foundation (No. 925100890). We thank the Guangzhou ImVin Pharmaceuticals Co., Ltd for providing the Chinese medicine Chuankezhi (CKZ).
中文摘要:

Chuankezhi(CKZ),a new Chinese medicine,plays an important role in immunoregulation.Cytokineinduced killer(CIK)cells have been commonly used for immunotherapy in recent years.In this study,we aimed to investigate the immunoregulatory effect of CKZ on CIK cells.Peripheral blood monocytes were isolated from healthy donors,and CIK cells were generated by culturing monocytes with interferon-gamma(IFN-γ)and interleukin 2.Different concentrations of CKZ were added on day 2.After incubation for 14days in culture,the antitumor effects of CIK cells were measured by cytotoxicity assay.Flow cytometry was used to explore the effect of CKZ on CIK cell immunophenotype,intracellular cytokine production,and apoptosis.The effect of CKZ on the antitumor activity of CIK cells in nude mice was also investigated.CKZ increased the percentage of CD3+CD56+CIK cells but did not significantly change the percentage of CD4+,CD8+,or CD4+CD25+CIK cells.CKZ-conditioned CIK cells showed a greater ability to kill tumor cells,as well as a higher frequency of IFN-γand TNF-αproduction,compared with the CIK cells in the control group.CKZ also suppressed the apoptosis of CIK cells in vitro.Furthermore,CKZ combined with CIK cells had a stronger suppressive effect on tumor growth in vivo than the CIK,CKZ,or normal saline control groups.Our results indicate that CKZ enhances the antitumor activity of CIK cells and is a potential medicine for tumor immunotherapy.

英文摘要:

Chuankezhi (CKZ), a new Chinese medicine, plays an important role in immunoregulation. Cytokineinduced killer (CIK) cells have been commonly used for immunotherapy in recent years. In this study, we aimed to investigate the immunoregulatory effect of CKZ on CIK cells. Peripheral blood monocytes were isolated from healthy donors, and CIK cells were generated by culturing monocytes with interferon-gamma (IFN-γ) and interleukin 2. Different concentrations of CKZ were added on day 2. After incubation for 14 days in culture, the antitumor effects of CIK cells were measured by cytotoxicity assay. Flow cytometry was used to explore the effect of CKZ on CIK cell immunophenotype, intracellular cytooine production, and apoptosis. The effect of CKZ on the antitumor activity of CIK cells in nude mice was also investigated. CKZ increased the percentage of CD3+CD56+ CIK cells but did not significantly change the percentage of CD4+, CD8+, or CD4+CD25+ CIK cells. CKZ-conditioned CIK cells showed a greater ability to kill tumor cells, as well as a higher frequency of IFN-γ and TNF-a production, compared with the CIK cells in the control group. CKZ also suppressed the apoptosis of CIK cells in vitro. Furthermore, CKZ combined with CIK cells had a stronger suppressive effect on tumor growth in vivo than the CIK, CKZ, or normal saline control groups. Our results indicate that CKZ enhances the antitumor activity of CIK cells and is a potential medicine for tumor immunotherapy.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《癌症:英文版》
  • 北大核心期刊(2008版)
  • 主管单位:教育部
  • 主办单位:中山大学肿瘤防治中心
  • 主编:曾益新
  • 地址:中国广州市东风东路651号
  • 邮编:510060
  • 邮箱:cjc@cjcsysu.cn
  • 电话:020-87345651
  • 国际标准刊号:ISSN:1000-467X
  • 国内统一刊号:ISSN:44-1195/R
  • 邮发代号:46-21
  • 获奖情况:
  • 广东省优秀期刊鼓励奖,1991年,2009、2010、2011年百杰期刊,2011-2014年RCCSE中国权威期刊,2012年中国国际影响力优秀学术期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),荷兰文摘与引文数据库,荷兰医学文摘,美国生物医学检索系统,美国剑桥科学文摘,美国科学引文索引(扩展库),日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),瑞典开放获取期刊指南,中国北大核心期刊(2000版)
  • 被引量:30766